Related Experiment Videos
Effects of FTY720 on rat lymphoid organs
K Takai1, S Takahara, N Isoyama
1Department of Urology, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan. takai@yamaguchi-u.ac.jp
Transplantation Proceedings
|November 25, 2004
Summary
FTY720 causes thymus atrophy and reduces T-cell areas in spleen, suggesting it may inhibit T-cell emigration from the thymus.
Area of Science:
- Immunology
- Pharmacology
Background:
- Investigated the in vivo effects of FTY720 on rat thymus and spleen.
- FTY720 is a sphingosine-1-phosphate receptor modulator with known immunomodulatory properties.
Purpose of the Study:
- To elucidate the in vivo impact of FTY720 on the thymus and spleen in a rat model.
- To understand the mechanism behind FTY720's immunosuppressive effects.
Main Methods:
- Administered FTY720 (0.1, 1, or 10 mg/kg) daily for 7 days to male Lewis rats.
- Collected thymus and spleen tissues at various time points (1, 3, 5, 7 days) post-administration.
- Performed hematoxylin and eosin (HE) staining and immunoperoxidase staining for CD4, CD8, and MHC class II.
Main Results:
- Observed significant thymic cortical atrophy in rats treated with 10 mg/kg FTY720.
- Noticed relative expansion of the thymic medulla due to cell accumulation by day 7.
- Detected a reduction in T-cell-dependent areas surrounding the central artery in the spleen of FTY720-treated rats.
Conclusions:
- FTY720 induces significant atrophy in the thymus cortex.
- The drug appears to reduce T-cell populations in the spleen's T-cell-dependent areas.
- The immunosuppressive effect of FTY720 may stem from inhibiting T-cell emigration from the thymus.